ArticleThe American journal of gastroenterology2026
Spontaneous Recovery and Mortality in Patients With ALD Referred for Early Liver Transplantation.
Article in The American journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
introductionAlcohol-associated liver disease (ALD), including alcohol-associated hepatitis, is the leading cause of liver transplant (LT) in the United States, and acceptance of LT without a mandatory period of abstinence is increasing. However, some patients may achieve spontaneous recovery (SR) without LT. We evaluated predictors of mortality and SR among patients with ALD referred for early LT.
methodsRecovery, survival, and outcomes-ALD is a retrospective cohort of adults with ALD and <6 months of sobriety referred for early LT between 2018 and 2021 at 6 transplant centers across the United States. Fine-Gray competing risk regression evaluated predictors of 12-month mortality, with LT considered as a competing risk. Multivariable logistic regression identified predictors of 12-month SR, defined by the expanded Baveno VII criteria.
resultsOf 607 patients, the median model for end-stage liver disease 3.0 was 29 (interquartile range [IQR] 22-36); the median time from last drink was 2.6 months (IQR 1.1-4.1). Independent predictors of 12-month mortality included higher international normalized ratio (INR) (sHR 1.49, 95% confidence interval [CI] 1.23-1.79) and higher blood urea nitrogen (sHR 1.16 per 10 mg/dL, 95% CI 1.07-1.25). After 12 months, 18.5% achieved SR without LT. Predictors of SR at 12 months were lower INR (odds ratio 0.52, 95%CI 0.31-0.83) and higher platelet count (odds ratio 1.04 per 10 × 10 3 /µL, 95%CI 1.01-1.08). DISCUSSION: Among patients with ALD and short-term abstinence, blood urea nitrogen and platelets are novel predictors of outcomes, along with INR. Using these predictors-or recalibrating existing model for end-stage liver disease coefficients-in this unique patient population may help refine medical selection criteria and improve utility and equity in access to early LT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.